Sonoma Pharmaceuticals, Inc. (SNOA)

Sonoma Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Sonoma Pharmaceuticals had annual revenue of $19.53M with 36.68% growth. Sonoma Pharmaceuticals had revenue of $5.56M in the quarter ending March 31, 2026, with 48.14% growth.

• Revenue (ttm): $19.53M
• Revenue Growth: +36.68%
• P/S Ratio: 0.28
• Revenue / Employee: $2,441,125
• Employees: 8
• Market Cap: 5.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	19.53M	5.24M	36.68%
Mar 31, 2025	14.29M	1.55M	12.19%
Mar 31, 2024	12.74M	-537.00K	-4.05%
Mar 31, 2023	13.27M	644.00K	5.10%
Mar 31, 2022	12.63M	-6.00M	-32.21%
Mar 31, 2021	18.63M	701.00K	3.91%
Mar 31, 2020	17.93M	-1.04M	-5.49%
Mar 31, 2019	18.97M	2.31M	13.88%
Mar 31, 2018	16.66M	3.83M	29.89%
Mar 31, 2017	12.83M	3.46M	36.89%
Mar 31, 2016	9.37M	-4.49M	-32.37%
Mar 31, 2015	13.85M	186.00K	1.36%
Mar 31, 2014	13.67M	-1.78M	-11.55%
Mar 31, 2013	15.45M	2.71M	21.25%
Mar 31, 2012	12.74M	2.99M	30.65%
Mar 31, 2011	9.75M	2.39M	32.46%
Mar 31, 2010	7.36M	1.98M	36.67%
Mar 31, 2009	5.39M	1.55M	40.50%
Mar 31, 2008	3.84M	-708.00K	-15.58%
Mar 31, 2007	4.54M	1.96M	75.81%
Mar 31, 2006	2.58M	1.23M	90.56%
Mar 31, 2005	1.36M	-	-

Data Source: Fiscal.ai Last updated: Jun 16, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 22, 2026

Data Sources Report a data error